Clinical Trials Browser

Phase 2 × Fulvestrant × Tumor-Agnostic × Clear all

NCT06979596 2026-03-06

OMAHA-015

Phase 2 Recruiting

Neoplasms

NCT05933395 2026-01-20

GERTRUDE

Phase 2 Recruiting

Neoplasm Metastasis

NCT04738292 2024-05-03

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

Phase 2 Terminated

11 enrolled 10 charts

Neoplasm Metastasis